JPRN-UMIN000010002已完成未知
Phase II study of pemetrexed maintenance with or without bevacizumab after a first line treatment chemotherapy with bevacizumab-carboplatin-pemetrexed in patients with advanced, metastatic or recurrent non-squamous non-small cell lung cancer - BPOP
Internal Medicine 2, Hamamatsu University School of Medicine.0 个研究点目标入组 110 人开始时间: 2013年2月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •interstitial lung disease history of hemoptysis myocardial infarction,unstable angina, stroke, transient ischemic attack significant vascular disease bleeding diathesis or coagulopathy in the absence of therapeutic anticoagulation hypertension or history of hypertensive crisis or encephalopathy; known CNS disease, except brain metastases treated with radiotherapy pregnancy abdominal fistula, or gastrointestinal perforation poorly controlled active ulcer known hypersensitivity to drug
研究者
相似试验
已完成
不适用
A randomized phase 2 study of maintenance pemetrexed versus docetaxel following pemetrexed plus carboplatin in advanced non-small cell lung cancerJPRN-UMIN000004075Hamamatsu University School of Medicine84
进行中（未招募）
不适用
Maintenance in elderly patient advanced Lung CancerEUCTR2012-005520-15-FRIFCT
招募中
不适用
Randomized phase II study of maintenance pemetrexed, bevacizumab, and pemetrexed+bevacizumab after induction chemotherapy with carboplatin+pemetrexed in advanced nonsquamous NSCLC.nonsquamous NSCLCJPRN-UMIN000006620Kyoto Thoracic Oncology Research Group99
已完成
2 期
Phase II study of continuation maintenance by use of TS1 after induction chemotherapy of cisplatin and TS1 in patients with Stage IIIB / IV non-small cell lung cancer-Research of efficacy predictive biomarkerJPRN-UMIN000009872Department of Respiratory Medicine National Center for Global health and Medicine14
已完成
2 期
Phase II study of continuation maintenance by use of TS1 and Bevacizumab after induction chemotherapy of cisplatin and TS1 pulse bevacizumab in patients with Stage IIIB / IV non-squamous and non-small cell lung cancer - Research of efficacy predictive biomarkerJPRN-UMIN000009871Department of Respiratory Medicine National Center for Global health and Medicine33